Clinical trialNCT05813288TerminatedPhase 3Interventional

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)

SponsorAreteia TherapeuticsEnrollment654AsthmaAsthma; EosinophilicEosinophilic Asthma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Michael E. Wechsler, MD
National Jewish Health
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

282 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Research Site -30054-043
Buenos Aires, Argentina
Research Site 30054-008
Buenos Aires, Argentina
Research Site 30054-012
Buenos Aires, Argentina
Research Site 30054-015
Buenos Aires, Argentina
Research Site 30054-021
Buenos Aires, Argentina
Research Site 30054-024
Buenos Aires, Argentina
Research Site 30054-026
Buenos Aires, Argentina
Research Site 30054-031
Buenos Aires, Argentina
Research Site 30054-034
Buenos Aires, Argentina
Research Site 30054-035
Buenos Aires, Argentina
Research Site 30054-044
Buenos Aires, Argentina
Research Site 30054-045
Buenos Aires, Argentina
Research Site 30054-048
Buenos Aires, Argentina
Research Site 30054-049
Buenos Aires, Argentina
Research Site 30054-050
Buenos Aires, Argentina
Research Site 30054-054
Concepción del Uruguay, Argentina
Research Site 30054-051
Córdoba, Argentina
Research Site 30054-052
Córdoba, Argentina
Research Site 30054-010
Mendoza, Argentina
Research Site 30054-028
Mendoza, Argentina
Research Site 30054-032
Mendoza, Argentina
Research Site 30054-047
Mendoza, Argentina
Research Site 30054-042
Santa Fe, Argentina

Austria

Research Site 30043-013
Salzburg, Austria
Research Site 30043-012
Vienna, Austria
Research Site 30043-001
Weiz, Austria

Brazil

Research Site 30055-036
Curitiba, Brazil
Research Site 30055-021
Porto Alegre, Brazil
Research Site 30055-035
Rio de Janeiro, Brazil
Research Site 30055-025
Salvador, Brazil
Research Site 30055-025
São Paulo, Brazil

Chile

Research Site 30056-013
Santiago, Providencia, Chile
Research Site 30056-009
Curicó, Chile
Research Site 30056-006
Santiago, Chile
Research Site 30056-007
Santiago, Chile
Research Site 30056-010
Santiago, Chile
Research Site 30056-011
Santiago, Chile
Research Site 30056-012
Santiago, Chile
Research Site 30056-013
Santiago, Chile
Research Site 30056-005
Temuco, Chile

242 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 27 Mar 2023
Primary completion: 8 Dec 2025
Completion: 8 Dec 2025
Last update posted: 15 Dec 2025
Registered enrollment: 654
Registry id: NCT05813288

Cross-registrations

EU-CTR / CTIS (EudraCT)2023-503693-20

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.